2017 ACCC Innovator Awards

Share: Share on FacebookTweet about this on TwitterShare on LinkedInEmail this to someone

In its seventh year, the Association of Community Cancer Centers (ACCC) Innovator Awards honor Cancer Program Members* for their pioneering achievements in oncology. Innovations should advance the goals of improving access, quality, and value in cancer care delivery.

In partnership with the Institute for Clinical Immuno-Oncology (ICLIO), ACCC will grant an Innovator Award to a program(s) that demonstrates innovation in the delivery of immunotherapies. Winners will be selected through a peer review process.

Criteria for Submissions:

  • Does your innovation present a new or improved approach to an issue often seen in treating patients with immunotherapy?
  • Does it have the potential to create positive change in the delivery of immunotherapy?
  • Is it replicable? Can it be adapted or integrated into practice at other community-based cancer programs?
  • Does it advance patients’ access to immunotherapies?
  • Does it improve care coordination for patients and providers, including interdisciplinary team members?
  • Will it be cost effective to implement? Result in cost saving or generate measurable ROI?

Winners will present their innovations at the ACCC 34th National Oncology Conference, October 18–20, 2017, in Nashville, TN, and will be featured in our journal, Oncology Issues. Winners receive regional and national exposure as their innovations are shared with oncology care providers, the broader healthcare community, and national press outlets.

The deadline for submissions is now closed.

Learn more about the ACCC Innovator Awards, Conference Presentation Details, and FAQs.

2016 ICLIO Innovator Awards

The Institute for Clinical Immuno-Oncology (ICLIO) selected Sanford Cancer Center in Sioux Falls, SD as the recipient of the 2016 ICLIO Innovator Award for its process improvement initiative enhancing patient treatment options, to include immunotherapy in the community setting. Read an interview with Steven Powell, MD, Sanford Cancer Center to learn how Sanford increases access to immunotherapy clinical trials through weekly tumor-specific video conferences and multidisciplinary molecular tumor boards.

Watch the video, for more details on their winning submission, Expanding Access to Immunotherapy in the Community Setting.

 

 

Share: Share on FacebookTweet about this on TwitterShare on LinkedInEmail this to someone